Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma

SIMPLE SUMMARY: Patients with gastric and oesophageal adenocarcinomas (GOCs) have short life expectancies as their tumours spread to other sites early. This is facilitated by the increased expression of the urokinase plasminogen activation system (uPAS); a feature of the majority of GOCs. There is i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tincknell, Gary, Piper, Ann-Katrin, Aghmesheh, Morteza, Becker, Therese, Vine, Kara Lea, Brungs, Daniel, Ranson, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393967/
https://www.ncbi.nlm.nih.gov/pubmed/34439251
http://dx.doi.org/10.3390/cancers13164097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393967/
https://www.ncbi.nlm.nih.gov/pubmed/34439251
http://dx.doi.org/10.3390/cancers13164097

Ejemplares similares